Discover the Monster Stocks in the Making You Can Invest in Right Now

Top 3 Potential Growth Stocks to Buy: Altimmune, Axsome Therapeutics, Viking Therapeutics

Discover the potential of Altimmune, Axsome Therapeutics, and Viking Therapeutics as they emerge as growth stocks in the market. These stocks might not be small for too much longer, mirroring the growth of Hyperion, the world's tallest tree in California's Redwood National Park.

Altimmune: A small-cap stock with big potential

• Exciting Drug: Altimmune's GLP-1 treatment, pemvidutide, shows promising results in weight loss, comparable to Wegovy.
• Market Potential: The anti-obesity drug market could exceed $100 billion, positioning Altimmune for substantial growth.

Axsome Therapeutics: A promising biotech on the ascent

• Diverse Portfolio: Axsome Therapeutics' late-stage pipeline with multiple therapies in phase 3 studies presents a high potential for success.
• Investment Opportunity: Investing in Axsome Therapeutics now could lead to significant returns in the future.

Viking Therapeutics: An especially promising pipeline

• Innovative Programs: Viking's clinical programs targeting NASH, obesity, and rare genetic diseases show positive results and market potential.
• Growth Prospects: Viking Therapeutics, with a large market cap, could grow significantly with successful pipeline candidates.

Investors looking for long-term growth opportunities in the biopharmaceutical sector should consider these potential growth stocks for their investment portfolios.